UK government partners with pharma on new £400M life science infusion
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
HAMBURG, Germany — Giving metformin early on to women with gestational diabetes failed to show a statistically significant benefit for the phase III EMERGE trial’s
The subcutaneous drug is already approved for ulcerative colitis and Crohn’s disease in Europe. Image credit: Shutterstock/Emily frost. The US Food and Drug Administration (FDA)